All Stories

  1. Atorvastatin and Fenofibrate Exert Opposite Effects on the Vascularization and Characteristics of Visceral Adipose Tissue in New Zealand White Rabbits
  2. The C4280A (rs5705) gene polymorphism of the renin (REN) gene is associated with risk of developing coronary artery disease, but not with restenosis after coronary stenting
  3. Epicardial adipose tissue mrna expression of genes coding for proteins related with calcium deposit is related to HDL subclasses in patients with coronary artery disease
  4. Adipose Tissue in Metabolic Syndrome: Onset and Progression of Atherosclerosis
  5. Atorvastatin and fenofibrate combination induces the predominance of the large HDL subclasses and increased apo AI fractional catabolic rates in New Zealand white rabbits with exogenous hypercholesterolemia
  6. Low concentrations of phospholipids and plasma HDL cholesterol subclasses in asymptomatic subjects with high coronary calcium scores
  7. The variant rs8048002 T>C in intron 3 of the MHC2TA gene is associated with risk of developing acute coronary syndrome
  8. Association of the suppressor of cytokine signaling 1 (SOCS1) gene polymorphisms with acute coronary syndrome in Mexican patients
  9. Early endothelial nitrosylation and increased abdominal adiposity in Wistar rats after long-term consumption of food fried in canola oil
  10. Distribution of ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms in a Mexican Mestizos population
  11. The −974C>A (rs3087459) gene polymorphism in the endothelin gene (EDN1) is associated with risk of developing acute coronary syndrome in Mexican patients
  12. HDL-cholesterol in coronary artery disease risk: Function or structure?
  13. The TGF-B1 and IL-10 gene polymorphisms are associated with risk of developing silent myocardial ischemia in the diabetic patients
  14. Toll-like receptor 4 gene polymorphisms and acute coronary syndrome: No association in a Mexican population
  15. The MHC2TA 1614 C>G gene polymorphism is associated with risk of developing acute coronary syndrome
  16. Effect of tomato consumption on high-density lipoprotein cholesterol level: a randomized, single-blinded, controlled clinical trial
  17. The Interleukin-1 Gene Cluster Polymorphisms Are Associated with Takayasu's Arteritis in Mexican Patients
  18. Normal HDL–apo AI turnover and cholesterol enrichment of HDL subclasses in New Zealand rabbits with partial nephrectomy
  19. LOW CHOLESTEROL AND PHOSPHATIDYLCHOLINE PLASMA CONCENTRATIONS OF HIGH-DENSITY LIPOPROTEINS SUBCLASSES IN SUBJECTS WITH CORONARY CALCIUM SCORE ABOVE THE 75TH PERCENTILE FOR AGE AND GENDER
  20. Shift of high-density lipoprotein size distribution toward large particles in patients with proteinuria
  21. The MHC2TA gene polymorphisms are not associated with restenosis after coronary stenting in Mexican patients
  22. The Srb1+1050T Allele Is Associated with Metabolic Syndrome in Children but Not with Cholesteryl Ester Plasma Concentrations of High-Density Lipoprotein Subclasses
  23. Lipid plasma concentrations of HDL subclasses determined by enzymatic staining on polyacrylamide electrophoresis gels in children with metabolic syndrome
  24. The Interleukin 6 - 572 G>C (rs1800796) Polymorphism Is Associated with the Risk of Developing Acute Coronary Syndrome
  25. 415 Abnormal Lipid Composition of Hdl Subclasses in Children with Metabolic Syndrome is Independent of Srbi (+1050T/C) and Adiponectin (+45T/G, +246G/T)Polymorphisms.
  26. Association of R230C ABCA1 gene variant with low HDL-C levels and abnormal HDL subclass distribution in Mexican school-aged children
  27. P250 LOW HDL-apoAI CLEARANCE ASSOCIATED TO INCREASED HDL3A AND HDL3B CHOLESTEROL PLASMA CONCENTRATIONS IN NEW ZEALAND RABBITS WITH PARTIAL NEPHRECTOMY
  28. Enzymatic assessment of cholesterol on electrophoresis gels for estimating HDL size distribution and plasma concentrations of HDL subclasses
  29. Rosiglitazone modifies HDL structure and increases HDL-apo AI synthesis and catabolic rates
  30. Association BetweenIL-1BandIL-1RNGene Polymorphisms and Chagas' Disease Development Susceptibility
  31. Palmitic acid in HDL is associated to low apo A-I fractional catabolic rates in vivo
  32. Abnormal HDL subclasses distribution in overweight children with insulin resistance or type 2 diabetes mellitus
  33. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene
  34. β1-adrenergic receptor gene polymorphisms in Mexican patients with idiopathic dilated cardiomyopathy
  35. Th-P15:186 Functional and metabolic characteristics of HDL in healthy subjects and cardiovascular disease (CVD) patients
  36. Th-P15:203 Abnormal HDL subclasses distribution in children with type 2 diabetes mellitus and insulin resistance obesity
  37. W10-P-027 Ciprofibrate enhances cholesterol efflux and the paraoxonase-1 association with HDL in hypertriglyceridemic patients
  38. W11.276 Pioglitazone induces hypercatabolism of HDL-apolipoprotein A-I in the rabbit
  39. W11.280 Ciprofibrate increases synthesis and catabolism of HDL apo AI and AII in patients with hyperlipidemia
  40. Contribution of Cholesteryl Ester Transfer Protein and Lecithin:Cholesterol Acyltransferase to HDL Size Distribution
  41. 4.W25.5 Contribution apo A-II and LCAT oblique peptides to HDL metabolism